| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2021―Dec―31 |
The need for a multi-level drug targeting strategy to curb the COVID-19 pandemic |
George J. Kontoghiorghes, Stella Fetta, Christina N. Kontoghiorghe |
| 2 |
[GO] |
2021―Dec―31 |
Potential links between COVID-19-associated pulmonary aspergillosis and bronchiectasis as detected by high resolution computed tomography |
Elisa Baratella, Erik Roman-Pognuz, Verena Zerbato, Pierluca Minelli, Marco Francesco Maria Cavallaro, Maria Assunta Cova, et al. (+11) Roberto Luzzati, Umberto Lucangelo, Gianfranco Sanson, Federica Friso, Rossana Bussani, Maurizio Pinamonti, Marina Busetti, Francesco Salton, Marco Confalonieri, Barbara Ruaro, Stefano Di Bella |
| 3 |
[GO] |
2021―Dec―31 |
Heterogeneity in susceptibility to hydroxychloroquine of SARS-CoV-2 isolates |
Celine Boschi, Marion Le Bideau, Julien Andreani, Sarah Aherfi, Priscilla Jardot, Jeremy Delerce, et al. (+5) Mathieu Gendrot, Bruno Pradines, Philippe Colson, Anthony Levasseur, Bernard La Scola |
| 4 |
[GO] |
2021―Dec―03 |
Metformin-associated lactic acidosis and acute kidney injury in the era of COVID-19 |
|
| 5 |
[GO] |
2021―Dec―01 |
Nutrition, atherosclerosis, arterial imaging, cardiovascular risk stratification, and manifestations in COVID-19 framework: a narrative review |
|
| 6 |
[GO] |
2021―Dec―01 |
Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials |
|
| 7 |
[GO] |
2021―Oct―29 |
Potential roles of mesenchymal stem cells and their exosomes in the treatment of COVID-19 |
|
| 8 |
[GO] |
2021―Oct―29 |
Effective inhibition of coronavirus replication by Polygonum cuspidatum |
|
| 9 |
[GO] |
2021―Sep―29 |
Clinical significance of inflammatory markers of bacterial infection in critically ill patients with COVID-19 after treatment with anti-inflammatory and immunomodulatory drugs: a complex new scenario |
|
| 10 |
[GO] |
2021―Aug―26 |
Challenges at the host-arthropod-coronavirus interface and COVID-19: a One Health approach |
|
| 11 |
[GO] |
2021―Jul―23 |
Key toolkits of non-pharmacological management in COPD: during and beyond COVID-19 |
|
| 12 |
[GO] |
2021―Jul―23 |
Can commercial automated immunoassays be utilized to predict neutralizing antibodies after SARS-CoV-2 infection? A comparative study between three different assays |
|
| 13 |
[GO] |
2021―May―31 |
A detailed review of the outbreak of COVID-19 |
|
| 14 |
[GO] |
2021―May―11 |
Review article on COVID-19 and Guillain-Barré syndrome |
|
| 15 |
[GO] |
2020―Oct―13 |
Insights into the COVID-19 pandemic: Origin, pathogenesis, diagnosis, and therapeutic interventions |
Mahmoud , M Berekaa |
